PHASE IIA TRIAL OF 1% TOPICAL CIDOFOVIR FOR TREATMENT OF HIGH-GRADE PERIANAL SQU

阶段%20IIA%20试验%20OF%201%%20局部%20西多福韦%20FOR%20治疗%20OF%20高等级%20肛周%20SQU

• 批准号: 8167120
• 负责人: RONALD T. MITSUYASU
• 金额: $ 0.15万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-12-01 至 2010-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8167120
• 关键词: Cidofovir; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Institution; Intraepithelial Neoplasia; Laboratories; Methods; Patient Self-Report; Phase; Research; Research Personnel; Resources; Safety; Signs and Symptoms; Source; United States National Institutes of Health; diaries

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To evaluate the safety and tolerability of topical cidofovir in HIV-infected subjects with high-grade perianal squamous intraepithelial neoplasia (perianal HSIL). (method: self-report daily sign & symptom diary, laboratory assessments)

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 目的：评价局部应用西多福韦治疗高度恶性肛周鳞状上皮内瘤变(HSIL)患者的安全性和耐受性。(方法：自述每日体征及症状日记、实验室评估)